5E Advanced Materials Files 8-K on Agreements and Equity Sales

Ticker: FEAV · Form: 8-K · Filed: Jan 14, 2025 · CIK: 1888654

Sentiment: neutral

Topics: material-agreement, equity-sale, financial-obligation

TL;DR

5E Advanced Materials just filed an 8-K detailing a new material agreement and equity sales - could be a financing move.

AI Summary

On January 10, 2025, 5E Advanced Materials, Inc. entered into a material definitive agreement, likely related to its financial obligations. The company also reported on unregistered sales of equity securities and provided a Regulation FD disclosure. This filing indicates potential new financing or operational developments for the company.

Why It Matters

This filing signals potential new financial commitments or equity issuances by 5E Advanced Materials, which could impact its capital structure and future operations.

Risk Assessment

Risk Level: medium — The filing involves material definitive agreements and unregistered equity sales, which can carry inherent risks related to financing and dilution.

Key Players & Entities

FAQ

What is the nature of the material definitive agreement entered into by 5E Advanced Materials?

The filing indicates the entry into a material definitive agreement, but the specific details of the agreement are not provided in the summary information.

When was the earliest event reported in this 8-K filing?

The earliest event reported was on January 10, 2025.

What other items are reported in this 8-K filing besides the material agreement?

The filing also reports on the creation of a direct financial obligation, unregistered sales of equity securities, Regulation FD disclosure, and other events.

What is the company's state of incorporation and principal executive office address?

The company is incorporated in Delaware and its principal executive office is located at 9329 Mariposa Road, Suite 210, Hesperia, California 92344.

What is the SIC code for 5E Advanced Materials, Inc.?

The Standard Industrial Classification code for 5E Advanced Materials, Inc. is 1400, which pertains to Mining, Quarrying of Nonmetallic Minerals (No Fuels).

Filing Stats: 3,462 words · 14 min read · ~12 pages · Grade level 15.5 · Accepted 2025-01-14 16:30:11

Key Financial Figures

Filing Documents

01 Entry into a Material Definitive Agreement

Item 1.01 Entry into a Material Definitive Agreement. Restructuring Support Agreement and Related Agreements On January 14, 2025, the Company entered into a Restructuring Support Agreement (the "Restructuring Support Agreement") with BEP Special Situations IV LLC ("Bluescape"), Meridian Investments Corporation ("Meridian") and Ascend Global Investment Fund SPC, for and on behalf of Strategic SP (together with Meridian, "Ascend") in connection with certain restructuring and recapitalization transactions with respect to the Company's capital structure (collectively the "Transaction"), including its senior secured convertible promissory notes issued pursuant to that certain Amended and Restated Note Purchase Agreement, dated as of January 18, 2024 (as amended, the "Note Purchase Agreement") by and among the Company, Bluescape, Ascend, the Guarantors from time to time party thereto and Alter Domus (US) LLC, as collateral agent. Pursuant to the Restructuring Support Agreement, the parties agreed to implement the Transaction either as an: Out-of-Court Restructuring : Subject to the satisfaction of customary conditions, including approval by the Company's stockholders, a recapitalization through, among other things: o pursuant to an Exchange Agreement dated January 14, 2025 among the Company, Ascend and Bluescape (the "Exchange Agreement"), the issuance of an aggregate of 312,490,076 shares of the Company's common stock, par value $0.01 per share ("Common Stock") to Ascend and Bluescape upon exchange of all of the outstanding Notes (as defined below) (the "Exchange"); o pursuant to a Securities Subscription Agreement dated January 14, 2025 among the Company, Ascend and Bluescape (the "Subscription Agreement"), the issuance and sale by the Company of an aggregate of $5.0 million of Common Stock to Ascend and Bluescape at a price per share equal to the lesser of (a) $0.2920 per share (appropriately adjusted to reflect any stock split, stock dividend, stock combin

02 Unregistered Sales of Equity Securities

Item 3.02 Unregistered Sales of Equity Securities. The disclosure contained in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference. The securities were offered in a private placement exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the "Securities Act").

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On January 14, 2025, the Company issued a press release announcing its entry into the Restructuring Agreement and the Transaction (the "Press Release"). A copy of the Press Release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The information contained in this Item 7.01 and in Exhibit 99.1 attached hereto is furnished pursuant to the rules and regulations of the Securities and Exchange Commission and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

01 Other Events

Item 8.01 Other Events. As previously disclosed, on November 21, 2024, the Company received written notice (the "Notice") from Nasdaq indicating that the Company's stockholders' equity of $2,094,000, as reported in its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, did not satisfy Nasdaq Listing Rule 5450(b)(1), which requires companies listed on the Nasdaq Global Select Market to maintain a minimum of $10,000,000 in stockholders' equity for continued listing (the "Stockholders' Equity Rule"). In accordance with the Notice, the Company had 45 days from the date of the Notice to submit to Nasdaq a plan to regain compliance with the Nasdaq Listing Rule 5450(b)(1), which the Company submitted on January 6, 2025. On January 10, 2025, Nasdaq informed the Company that the request for extension to evidence compliance with the Stockholders' Equity Rule was granted. As a result of the extension, the Company now has until May 19, 2025 to provide evidence that it has completed the Transaction and has regained compliance with the Stockholders' Equity Rule. There can be no assurance that the Company will be successful in implementing its plan to regain compliance with the Stockholders' Equity Rule, or will otherwise be in compliance with other Nasdaq Listing Rules.

Forward-Looking Statements

Forward-Looking Statements This Current Report includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. All statements other than statements of historical fact included in this Current Report regarding our business strategy, plans, goal, and objectives are forward-looking statements, including without limitation statements regarding the Company's ability to consummate the Transaction and its intent or ability to regain compliance with any applicable Nasdaq listing requirements. When used in this Current Report, the words "believe," "project," "expect," "anticipate," "estimate," "intend," "seek," "budget," "target," "aim," "strategy," "plan," "guidance," "outlook," "intent," "may," "should," "could," "will," "would," "will be," "will continue," "will likely result," and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. These forward-looking statements are based on the Company's current expectations and assumptions about future events and are based on currently available information as to the outcome and timing of future events. Forward-looking statements are subject to all of the risks and uncertainties, most of which are difficult to predict and many of which are beyond our control, incident to the extraction of the critical materials we intend to produce and advanced materials production and development. These risks include, but are not limited to: the substantial doubt regarding our ability to continue as a going concern; our need for substantial additional financing to continue as a going concern and advance our development and operations; the significant net operating losses incurred since our inception and anticipation of the same net operating losses for the foreseeable future; the de-listing of our securities from Nasdaq, which could limit investors' ability to transact in our securities, sub

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 10.1 Restructuring Support Agreement, dated January 14, 2025. 10.2 Exchange Agreement, dated January 14, 2025. 10.3 Securities Subscription Agreement, dated January 14, 2025. 10.4 Form of Warrant. 10.5 Fourth Amended and Restated Investor and Registration Rights Agreement, dated January 14, 2025. 10.6 Amendment No. 4 to the Amended and Restated Note Purchase Agreement, dated January 14, 2025. 99.1 Press Release, dated January 14, 2025. 104 Cover Page Interactive Data File (embedded with the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. 5E Advanced Materials, Inc. Date: January 14, 2025 By: /s/ Paul Weibel Paul Weibel Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing